comparemela.com

Latest Breaking News On - Bio developments - Page 3 : comparemela.com

Purolite innovates biopharma with jetted resin

In a recent interview, Hayley Crowe, head of Ecolab's global life sciences business, shed light on Purolite's latest developments and its significant contributions to the biopharmaceutical industry.

Women in Science Wednesday - Karen Ooms journey to Quanticate

From a child's chemistry set given to her by her grandfather to watching Open University maths programs, Karen Ooms seemed destined for a career in science.

Could placenta-derived cells revolutionize age-related disease treatment?

Celularity, a biotech company specializing in placental-derived allogeneic cell therapies, will be showcasing data at the upcoming ASGCT Annual Meeting, showcasing the potential of their off-the-shelf natural killer (NK) cells to combat age-related diseases.

SynOx Therapeutics secures $75m to fund tenosynovial giant cell tumor trial

SynOx Therapeutics has raised $75m in Series B financing, co-led by Forbion, HealthCap and new investor Bioqube Ventures.

Selkirk Pharma: Adapting to regulatory shifts and market demand

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.